FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W3156960087> ?p ?o ?g. }

• W3156960087 abstract "Today, achieving clinical control in patients with chronic obstructive pulmonary disease (COPD) remains relevant. Thus, the results of a large multicenter study of clinical efficacy of dual bronchodilatory therapy in real practice conducted in Eastern Europe, including the Russian Federation, are of great interest. Aim. Assessment of changes in the clinical control in patients with COPD receiving treatment with LABA/LAMA combination (tiotropium/olodaterol 5/5 μg via the Respimat® inhaler) in real clinical practice. Methods. The study included patients (n = 1 476) with COPD older than 40 years who were prescribed tiotropium/olodaterol 5/5 μg via the Respimat® inhaler according to the current Russian and foreign clinical guidelines. The observation period was 6 weeks. The clinical control of COPD was assessed by the CCQ questionnaire, the patient’s general condition, the severity of dyspnea according to the mMRC scale, the incidence of using short-acting bronchodilators to relieve symptoms. The criterion for therapeutic success was a 0.4 point decrease in the CCQ score, the minimal clinically important difference Results. The treatment with tiotropium/olodaterol 5/5 μg was successful, i.e., led to a decrease in the number of CCQ points by more than 0.4 points, in 89.84% of patients (95% CI 88.2 – 91.3 %; p < 0.0001). On average, the overall CCQ score between the first and second visit decreased by 1.31 ± 0.97 points, the severity of symptoms – by 1.39 ± 1.03 points, the functional state – by 1.2 ± 1.1 points, the mental condition – by 1.38 ± 1.31 CCQ points. Achievement of clinical control did not depend on comorbid pathology, disease severity, patient age, and the previous therapy. Conclusion. The results obtained on a wide sample of patients from real practice confirmed the high clinical efficacy of tiotropium/olodaterol 5/5 μg in achieving clinical control of COPD." @default.
• W3156960087 created "2021-04-26" @default.
• W3156960087 creator A5007911251 @default.
• W3156960087 creator A5029284595 @default.
• W3156960087 creator A5033053050 @default.
• W3156960087 creator A5047828753 @default.
• W3156960087 creator A5089398692 @default.
• W3156960087 date "2021-04-11" @default.
• W3156960087 modified "2023-09-26" @default.
• W3156960087 title "The effect of dual bronchodilatory therapy on the clinical control of chronic obstructive pulmonary disease in real clinical practice" @default.
• W3156960087 doi "https://doi.org/10.18093/0869-0189-2021-31-2-216-224" @default.
• W3156960087 hasPublicationYear "2021" @default.
• W3156960087 type Work @default.
• W3156960087 sameAs 3156960087 @default.
• W3156960087 citedByCount "0" @default.
• W3156960087 crossrefType "journal-article" @default.
• W3156960087 hasAuthorship W3156960087A5007911251 @default.
• W3156960087 hasAuthorship W3156960087A5029284595 @default.
• W3156960087 hasAuthorship W3156960087A5033053050 @default.
• W3156960087 hasAuthorship W3156960087A5047828753 @default.
• W3156960087 hasAuthorship W3156960087A5089398692 @default.
• W3156960087 hasConcept C126322002 @default.
• W3156960087 hasConcept C1862650 @default.
• W3156960087 hasConcept C2776042228 @default.
• W3156960087 hasConcept C2776780178 @default.
• W3156960087 hasConcept C2776968687 @default.
• W3156960087 hasConcept C2777714996 @default.
• W3156960087 hasConcept C2779974597 @default.
• W3156960087 hasConcept C2780261241 @default.
• W3156960087 hasConcept C2780911369 @default.
• W3156960087 hasConcept C2992779976 @default.
• W3156960087 hasConcept C3018587741 @default.
• W3156960087 hasConcept C42219234 @default.
• W3156960087 hasConcept C71924100 @default.
• W3156960087 hasConceptScore W3156960087C126322002 @default.
• W3156960087 hasConceptScore W3156960087C1862650 @default.
• W3156960087 hasConceptScore W3156960087C2776042228 @default.
• W3156960087 hasConceptScore W3156960087C2776780178 @default.
• W3156960087 hasConceptScore W3156960087C2776968687 @default.
• W3156960087 hasConceptScore W3156960087C2777714996 @default.
• W3156960087 hasConceptScore W3156960087C2779974597 @default.
• W3156960087 hasConceptScore W3156960087C2780261241 @default.
• W3156960087 hasConceptScore W3156960087C2780911369 @default.
• W3156960087 hasConceptScore W3156960087C2992779976 @default.
• W3156960087 hasConceptScore W3156960087C3018587741 @default.
• W3156960087 hasConceptScore W3156960087C42219234 @default.
• W3156960087 hasConceptScore W3156960087C71924100 @default.
• W3156960087 hasLocation W31569600871 @default.
• W3156960087 hasOpenAccess W3156960087 @default.
• W3156960087 hasPrimaryLocation W31569600871 @default.
• W3156960087 hasRelatedWork W10414013 @default.
• W3156960087 hasRelatedWork W12611789 @default.
• W3156960087 hasRelatedWork W126835 @default.
• W3156960087 hasRelatedWork W129920 @default.
• W3156960087 hasRelatedWork W15963216 @default.
• W3156960087 hasRelatedWork W17572523 @default.
• W3156960087 hasRelatedWork W20608639 @default.
• W3156960087 hasRelatedWork W4124819 @default.
• W3156960087 hasRelatedWork W6673473 @default.
• W3156960087 hasRelatedWork W7168267 @default.
• W3156960087 isParatext "false" @default.
• W3156960087 isRetracted "false" @default.
• W3156960087 magId "3156960087" @default.
• W3156960087 workType "article" @default.